Karl‐Heinz Kurth

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations

Medicine, Oncology, Urology +10

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 683 citations

Medicine, Surgery, Urology +10

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial

Philip W. Friederich, C. P. Henny, Embert J. Messelink et al. · The Lancet · 2003 · 413 citations

Medicine, Perioperative Medicine, Surgery +12

IMPROVED DETECTION AND TREATMENT OF BLADDER CANCER USING HEXAMINOLEVULINATE IMAGING: A PROSPECTIVE, PHASE III MULTICENTER STUDY

D. Jocham, Fred Witjes, Sigrid Wagner et al. · The Journal of Urology · 2005 · 333 citations

Medicine, Oncology, Urology +16

Significance of Bladder Biopsies in Ta,T1 Bladder Tumors: A Report from the EORTC Genito-Urinary Tract Cancer Cooperative Group

Adrian van der Meijden, W. Oosterlinck, Maurizio Brausi et al. · European Urology · 1999 · 170 citations

Medicine, Oncology, Urology +14